๎
๎ผ
๎
LAVA Therapeutics NV
LVTX๎น
์์ธ ์ฐจํธ ๋ณด๊ธฐ
1.740USD
0.0000.00%
์ข
๊ฐย 02/06, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
45.77M์๊ฐ์ด์ก
์์คP/E TTM
๎
Intraday
1m
30m
1h
D
W
M
D
์ค๋
0.00%
5์ผ
0.00%
1๊ฐ์
0.00%
6๊ฐ์
+13.73%
์ฌํด ํ์ฌ๊น์ง
0.00%
1๋
+84.13%
์์ธ ์ฐจํธ ๋ณด๊ธฐ
TradingKey ์ฃผ์ ์ ์
๋ฐ์ดํฐ๊ฐ ๋ถ์กฑํ์ฌ ์ฃผ์ ์ ์๋ฅผ ํ์ธํ ์ ์์ต๋๋ค.
LAVA Therapeutics NV ๋ด์ค
๋ ๋ง์ ๋ด์ค๊ฐ ๊ณง ์
๋ฐ์ดํธ๋ฉ๋๋ค. ๊ณ์ ์ง์ผ๋ด ์ฃผ์ธ์โฆ
์ฌ๋ฌด ์งํ๎
EPS
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ด ์์ต
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
LAVA Therapeutics NV ์ ๋ณด๎
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
์ข
๋ชฉ ์ฝ๋ LVTX
ํ์ฌLAVA Therapeutics NV
CEOMr. Stephen A. Hurly
์น์ฌ์ดํธhttps://www.lavatherapeutics.com/
๊ด๋ จ ์ํ
+3.66%
+3.14%
+0.93%
+2.01%
+1.82%
+1.60%
-0.95%
+4.49%
+2.10%
+9.92%
+2.76%
+4.15%
+1.79%
+4.17%
+0.72%
+1.10%
+2.46%
0.00%
+0.51%
+0.54%์ธ๊ธฐ ์ฌ๋ณผ
278.120
+2.210ย (+0.80%)
185.410
+13.530ย (+7.87%)
68067.520
-1902.610ย (-2.72%)
282.580
+22.390ย (+8.61%)
2024.860
-26.870ย (-1.31%)
411.110
+13.900ย (+3.50%)
4952.980
+142.360ย (+2.96%)
63.303
+0.206ย (+0.33%)
1.182
+0.004ย (+0.35%)
157.098
+0.057ย (+0.04%)
